La empresa farmacéutica Merck indicó este viernes que su pastilla contra el COVID-19 reduce en alrededor del 50 % el riesgo de hospitalización o muerte, según los resultados de un estudio clínico.
Merck y Ridgeback Biotherapeutics, que desarrollaron el medicamento, solicitarán una autorización para uso en emergencia a las autoridades sanitarias de Estados Unidos y pedirán permisos de comercialización en otras agencias regulatorias en el mundo.
En su anuncio, Merck indicó que el análisis interino de los resultados en el uso del compuesto Molnupiravir mostró que el 7,3 % de los pacientes que recibieron el medicamento fue hospitalizado dentro de los 29 días siguientes.
Dentro de los 29 días de la prueba, el 14,1 % de los pacientes que recibieron un placebo, fue hospitalizado o murió.
No hubo muertes entre los pacientes que recibieron molnupiravir, en tanto que murieron ocho pacientes del grupo que recibió un placebo.
«Si se autoriza el uso, Molnupiravir podría ser el primer medicamento antiviral de uso oral para la COVID-19», añadió la firma.
Molnupiravir se administra por vía oral y funciona inhibiendo que el coronavirus se replique dentro del cuerpo.
Por: Agencia
892463 832463Outstanding read, I just passed this onto a colleague who was performing just a little research on that. And he really bought me lunch because I identified it for him smile So let me rephrase that. 349379
857399 797302Following study quite a few the websites along with your site now, and that i genuinely appreciate your method of blogging. I bookmarked it to my bookmark internet site list and are checking back soon. Pls have a appear at my internet page likewise and let me know in the event you agree. 236203
15534 801188Yay google is my world beater assisted me to uncover this excellent internet site! . 482404
819641 768834Have read a couple of of the articles on your internet site now, and I actually like your style of blogging. I added it to my favorites weblog site list and will probably be checking back soon. 310888
121953 194930I adore foregathering beneficial information, this post has got me even much more info! . 15550
522238 816982It is rare knowledgeable folks within this subject, nevertheless, you seem like theres much more you are talking about! Thanks 979264
14613 556686Some actually good stuff on this internet website , I enjoy it. 287864
829167 24123Rattling excellent information can be discovered on web weblog . 308174
898258 580871Im impressed, I need to say. Genuinely rarely do you encounter a weblog thats both educative and entertaining, and let me let you know, you could have hit the nail about the head. Your concept is outstanding; ab muscles something that too few folks are speaking intelligently about. Im delighted i located this in my hunt for something about it. 49561
532595 182715This is the very first time I frequented your website page and thus far? I amazed with the analysis you made to create this particular post extraordinary. 763796
565470 382078Register a domain, search for available domains, renew and transfer domains, and pick from a wide variety of domain extensions. 633523
569880 769829i was just browsing along and came upon your web site. just wantd to say great job and this post genuinely helped me. 760869
334585 724297Thank you for your really excellent data and respond to you. I need to verify with you here. Which isnt one thing I often do! I get pleasure from reading a publish that can make people think. Additionally, thanks for allowing me to remark! 998220
435231 558409Quite interesting subject , regards for putting up. 716191
710296 240516I adore foregathering useful info, this post has got me even much more info! . 147497